health 43

This reveals subgroup averages of parametric maps of MRI mind iron indices: magnetic subject correlation (MFC: prime row) and leisure charges R2 (second row), R2*(third row), and R2' (backside row). Parametric maps, masked for areas of pursuits (inexperienced): caudate nucleus (CN), putamen (PUT), globus pallidus (GP) and thalamus (THL), are proven for controls (n = 27), medication-naïve ADHD sufferers (ADHD-non-medicated; n = 12) and ADHD sufferers with a historical past of psychostimulant remedy (ADHD-medicated; n = 10). The ADHD-non-medicated subgroup displayed considerably lowered striatal (CN, PUT) and thalamic MFC in comparison with each controls and the ADHD-medicated subgroup . No important variations had been detected between the latter two teams. Credit score: Radiological Society of North America Mind iron ranges provide a possible biomarker within the analysis of consideration defi...

"Our work in several ways shows that most likely there is no link between treatment with ADHD drugs and an increased risk of suicide attempts or suicide. The results rather indicate that ADHD drugs may have a protective effect," says Henrik Larsson , researcher at the Department of Medical Epidemiology and Biostatistics, who headed the study. Earlier research has indicated that ADHD drug treatment would increase the occurrence of suicidal thoughts. However, these studies have been small scale and/or the methods used have been limited, which make the results uncertain. To gain clarity in this matter, researchers at Karolinska Institutet have now used national patient registers to identify all patients in Sweden diagnosed with ADHD between 1960 and 1996; a total of 37,936 individuals. These people were then followed over the period 2006-2009, in terms of drug treatment and events that could be linked to suicide attempts and suicide. Among other things, the study compared...

"Our research shows that when people see others using ability-boosting products , they are more likely to see this behavior as morally unacceptable than if they were using the products themselves," write authors Elanor F. Williams (University of California, San Diego) and Mary Steffel (University of Cincinnati). Studying what they call an ethical double standard, the authors conducted five experiments to understand how people perceive the use and regulation of products and services designed to enhance one's ability, performance, appearance, potential, or well-being. In one study, participants were asked to imagine either taking or not taking a medication to improve their focus and concentration while taking an exam. Also taking the exam were people either diagnosed or not diagnosed with ADHD. When outperformed on the test by those taking the medication, participants were more likely to view taking the medication without having ADHD as embellishing one's per...

"This study doesn't address whether ADHD drugs are safe, though their safety has since been established through years of clinical experience," says study s enior author Kenneth Mandl, MD, MPH, Boston Children's chair in biomedical informatics and population health and director of the Intelligent Health Laboratory in Boston Children's Informatics Program. "Instead, we point to the need for an agenda emphasizing improved assessment of rare adverse events and long-term safety through post-marketing trials, comparative effectiveness trials and more active FDA enforcement." According to the U.S. Centers for Disease Control and Prevention, 11 percent of children in the U.S. between the ages of four and 17 -- or about 6.4 million children -- have been diagnosed with ADHD. On average, children prescribed ADHD medications take them for several years. To understand how extensively the long-term safety of common ADHD medications had been studied before going ...

In DSM-5, age of onset criterion for ADHD, previously set at 7 in DSM-IV, has been raised to 12. As explained in DSM-5, age of onset is now set at 12, rather than an earlier age, to reflect the importance of clinical presentation during childhood for accurate diagnosis, while also acknowledging the difficulties in establishing precise childhood onset retrospectively. Using data from a nationally representative sample of youth who participated in the National Health and Nutrition Examination Survey (NHANES), a group of researchers led by Dr. Kathleen Merikangas of the National Institute of Health Intramural Research Program, evaluated symptoms of ADHD and its subtypes in 1,894 participants aged 12-15 years based on parent reports of symptomatology. Researchers found that levels of severity, functional impairment, and patterns of comorbidity among the additional 3.46% of children who met all of the ADHD criteria except age of onset under 7 were comparable with those of other me...

Arti Lal, MD, a pediatrician who specializes in treating patients at the ADHD Clinic at Scott & White in North Austin, is currently utilizing a new technology on patients which is called the Quotient® ADHD Test. It is FDA-cleared for the objective measurement of hyperactivity, impulsivity and inattention, as an aid in the assessment of ADHD. The test measures motion and analyzes shifts in attention state to give an assessment of the core symptom areas of ADHD: • Hyperactivity • Impulsivity • Inattention "Since ADHD shares traits with other mental health conditions, it can be difficult to diagnose. So, a thorough assessment by a trained professional is critical. The test is a more objective test than previous methods of diagnosis and will serve as an additional tool for us as clinicians," Dr. Lal said. "Testing can be done from age six to 55 years." The test can also be used to quantify severity of deficits in brain function associated with controlling motio...